Profile image
By ETF Daily News (Reporter)
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

Is Abiomed A Buy Again After Its Huge Pullback?

Friday, October 28, 2016 3:57
% of readers think this story is Fact. Add your two cents.

abiomed-logoFrom Taki Tsaklanos: Medical implant maker Abiomed, Inc. (NASDAQ:ABMD) was hit hard yesterday. Is there more danger ahead, or is the pullback another buying opportunity?

The company released earnings yesterday, and fell some 15% during the session, only to recover to a fall of 7% at the close. Is this mini-crash justified or not? In other words, are we looking at a buying opportunity or is this a strong sell?

Let’s first analyze revenues. Below is the overview since the first fiscal quarter of last year:

$73M Q1 FY16
$76M Q2 FY16
$85M Q3 FY16
$93M Q4 FY16
$103M Q1 FY17
$103M Q2 FY17 (quarter ending September 30th of this year)

Now the company’s outlook for FY17 remains at$440M, which implies on average $117M for the next two quarters. That implies a revenue growth of around 14%, which is in line with revenue growth in previous quarters. So that’s an excellent outlook.

From a profitability perspective, the EPS dropped slightly from $0.29 in Q1 FY17 to $0.20 in the latest quarter (EPS was $0.17 in the quarter one year before).

The company is still debt free. The cash position is $236M, up 5% from the previous quarter. There was a slight increase in shares outstanding, slight dilution in other words.

We don’t see any valid reason for concern based on the above data.

Moreover, from a chart perspective, we notice that the stock retraced from a steep rise, only to come to closely to its long term moving average. The stock has seen volatility in the past, so, again, no real reason for concern.

We would say that the $90 level is the key level to watch. We do not expect it will be breached, if so, it would be a very bearish sign. We believe, though, that the decline will not continue, and that the uptrend will continue in the coming weeks. We are not selling our positions at this point, and, depending on price action in the coming days and weeks, would consider an additional position, but only if the decline stops at this level.


This article is brought to you courtesy of Investing Haven.

You are viewing an abbreviated republication of ETF Daily News content. You can find full ETF Daily News articles on (


We encourage you to Share our Reports, Analyses, Breaking News and Videos. Simply Click your Favorite Social Media Button and Share.

Report abuse


Your Comments
Question Razz Sad Evil Exclaim Smile Redface Biggrin Surprised Eek Confused Cool LOL Mad Twisted Rolleyes Wink Idea Arrow Neutral Cry Mr. Green

Top Stories
Recent Stories



Top Global

Top Alternative



Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.